When Chest Tubes Go Wrong: How a Vascular Plug Can Save the Day
"A minimally invasive technique offers a solution when a chest tube accidentally enters the liver."
Chest tubes are essential tools in managing various thoracic conditions, such as pleural effusions and pneumothoraxes. However, the insertion of these tubes isn't always straightforward, and complications can arise, including misplacement. While rare, one particularly dangerous complication occurs when a chest tube inadvertently punctures the liver. This can lead to significant bleeding and require immediate intervention to prevent life-threatening consequences.
A recent case report highlighted in Cardiovascular and Interventional Radiology details a scenario where a 70-year-old man experienced this exact complication. Following chest tube insertion to address a collapsed lung and pleural effusion, the tube was found to have penetrated the liver, traveling through the hepatic vein and reaching the right ventricle of the heart. This prompted an emergency response and a clever solution from interventional radiologists.
Traditionally, managing such complications would involve more invasive surgical procedures. However, advancements in interventional radiology have paved the way for less invasive approaches. The article we're diving into showcases the use of an Amplatzer Vascular Plug (AVP) to effectively embolize, or block, the misplaced chest tube tract in the liver. This technique offers a minimally invasive alternative to open surgery, reducing patient risk and recovery time.
Errant Chest Tube Tracts
A 2019 report in Cardiovascular and Interventional Radiology describes using an Amplatzer Vascular Plug to embolize an errant chest tube tract in the liver. The article was published online on November 5, 2018, and appeared in volume 42, pages 478–480. The reported application is presented as a way to address a potentially life-threatening complication caused by a malpositioned chest tube.
Mechanical Embolization Options
The Amplatzer Vascular Plugs are described as non-absorbable mechanical embolization devices, alongside coils and occlusion balloons. The devices were derived from septal occlusion plugs originally developed for congenital heart defects by Dr. Kurt Anton Amplatz. A separate summary reports that Amplatzer Vascular Plugs appear to be a safe and effective method for embolizing tracts created by malpositioned chest tubes, while emphasizing that individual patient factors must be considered.
The Amplatzer Plug Family
Abbott describes the Amplatzer family of vascular plugs as a group of devices intended for peripheral embolization. The company says the family addresses different vessel conditions. This represents the device platform's continuing development as a set of vascular plugs rather than a single device for one clinical situation.
The Case of the Misplaced Chest Tube: A Step-by-Step Rescue
The initial chest tube insertion in the 70-year-old patient led to a rapid loss of blood, triggering cardiopulmonary resuscitation. Imaging revealed the alarming path of the chest tube through the liver and into the heart. Fortunately, the patient's condition was stabilized, allowing time for a planned intervention.
- Careful Withdrawal: Under fluoroscopic guidance, the chest tube was carefully withdrawn to the inferior vena cava (IVC), using the patient's vertebral contours as landmarks.
- Guidewire and Catheter Placement: A 0.035-inch hydrophilic guidewire and a 5-Fr catheter were advanced through the chest tube into the IVC, then pulled back into the hepatic vein, creating a pathway for the AVP.
- AVP Deployment: A 6-mm Amplatzer vascular plug (AVP) IV was advanced through the catheter and strategically placed to block the liver tract. The AVP was initially positioned in the hepatic vein and then pulled back to the hepatic parenchyma.
- Confirmation and Release: The team used a nearby liver calcification and patient feedback to estimate the vein-tract junction and ensure correct AVP placement. Once satisfied that there was no bleeding, the AVP was detached, and the chest tube and catheter were removed.
The AVP Advantage: A Safe and Effective Alternative
The use of AVPs to embolize errant chest tube tracts appears to be a safe and effective method, especially when compared to more invasive surgical options. The minimally invasive nature of the procedure translates to reduced patient risk, shorter recovery times, and a decreased likelihood of complications. However, it's important to note that patients with hepatic congestion may require alternative approaches, such as occlusive balloons, to manage bleeding effectively.
Projected Market Growth
The Vascular Plugs Market is valued at US$287.2 million in 2026, according to the cited market outlook. The report projects a compound annual growth rate of 5.4%. It forecasts the market reaching US$363.8 million by 2034.
Complex Vascular Applications
The indexed record includes a report on transcatheter Amplatzer vascular plug embolization of a giant postnephrectomy arteriovenous fistula combined with an aneurysm of the renal pedicle. The procedure used through-and-through arteriovenous access. This example places vascular plug treatment within complex post-surgical vascular conditions beyond errant chest tube tracts.
Diagnostic Complexity
In the reported clinical case, subsequent diagnostic evaluation included computed tomography. The CT revealed a right apical lung mass that appeared to invade the chest wall. During the intervention, clinicians passed a 0.035-inch hydrophilic guidewire and used a 5-Fr catheter, with the cited materials identifying Radifocus by Terumo in Tokyo, Japan.